ABSTRACT
AIM: To investigate the composition of the microbial community in biodeterioration of two frescoes in St Damian's Monastery in Assisi. METHODS AND RESULTS: A total of 1292 colonies were isolated from the most deteriorated parts, analysed by microbiological, biomolecular and ultrastructural techniques, and taxonomically classified. Molecular biotyping of Staphylococcus cohnii colonies, one of the most prevalent bacterial species, showed a very restricted genome diversity while Bacillus licheniformis were very homogeneous by RFLP, tDNA-PCR and random-amplified polymorphic DNA. Electron microscopy confirmed heterogeneity of the bacterial population in the different sampling areas. CONCLUSIONS: Several of the identified species are widespread in the soil or saprophytes of human skin. Although unable to demonstrate that they are involved in biodeterioration, they may represent trophic elements contributing to fungi-related chromatic alterations when adequate environmental conditions occur. Deterioration may in part be prevented or controlled by adequate air filtering or conditioning of the room.
Subject(s)
Bacteria/classification , Bacteria/genetics , Paintings , Alcaligenes/classification , Alcaligenes/genetics , Alcaligenes/isolation & purification , Bacillus/classification , Bacillus/genetics , Bacillus/isolation & purification , Bacillus/ultrastructure , Bacteria/isolation & purification , Bacteria/ultrastructure , Bacterial Typing Techniques , Biodiversity , Corynebacterium/classification , Corynebacterium/genetics , Corynebacterium/isolation & purification , DNA Fingerprinting , DNA, Bacterial/analysis , DNA, Bacterial/isolation & purification , Fungi/isolation & purification , Fungi/ultrastructure , Genes, Bacterial/genetics , Italy , Micrococcus/classification , Micrococcus/genetics , Micrococcus/isolation & purification , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Pseudomonas/classification , Pseudomonas/genetics , Pseudomonas/isolation & purification , RNA, Transfer/genetics , Random Amplified Polymorphic DNA Technique , Staphylococcus/classification , Staphylococcus/genetics , Staphylococcus/isolation & purification , Staphylococcus/ultrastructureABSTRACT
Nine polyvalent human influenza virus vaccines were tested by reverse transcriptase-polymerase chain reaction (RT-PCR) for the presence of pestivirus RNA. Samples were selected from manufacturers in Europe and the USA. Three samples of the nine vaccines tested (33.3%) gave positive results for pestivirus RNA. The 5'-untranslated genomic region sequence of the contaminant pestivirus RNA was analysed based on primary nucleotide sequence homology and on secondary sequence structures characteristic to genotypes. Two sequences belonged to Pestivirus type-1 (bovine viral diarrhoea virus [BVDV]) species, genotypes BVDV-1b and BVDV-1e. These findings confirm previous reports, suggesting an improvement in preventive measures against contamination of biological products for human use.
ABSTRACT
Live virus vaccines for human use, 29 monovalent vaccines against measles, mumps, rubella or polio, eight polyvalent vaccines against measles-mumps-rubella and one bacterial polyvalent vaccine against Streptococcus pneumoniae, were tested by reverse transcriptase-nested PCR for the presence of petivirus or pestivirus RNA. Twenty-four samples were selected from European manufacturers, ten were from U.S.A. and four from Japan. Five (13.1%) out of 38 tested samples were positive for pestivirus RNA. Three vaccines (rubella and two measles) were from Europe and two (mumps and rubella) from Japan. The 5'-untranslated genomic region of the contaminant pestivirus RNA were amplified by reverse transcription-PCR and sequenced. Analyses based on primary nucleotide sequence homology and on secondary structures, characteristic to genotypes, revealed that the cDNA sequences belonged to bovine viral diarrhea virus (BVDV). A cDNA sequence, detected from one measles sample, belonged to BVDV-1b genotype. Pestiviral cDNA detected from the Japanese mumps and rubella vaccine samples, belonged to the BVDV genotypes 1a and 1c, respectively. Analysis on two cDNA sequences detected from measles and rubella vaccine samples from Europe showed their appurtenance to a new genotype, BVDV-1d. These findings indicate that contamination by animal pestivirus may occur in biological products for human use.
Subject(s)
Diarrhea Virus 1, Bovine Viral/genetics , RNA, Viral/genetics , Viral Vaccines/genetics , 5' Untranslated Regions/chemistry , 5' Untranslated Regions/genetics , Animals , Base Sequence , DNA, Complementary/chemistry , DNA, Complementary/genetics , Diarrhea Virus 1, Bovine Viral/isolation & purification , Electrophoresis, Agar Gel , Humans , Japan , Molecular Sequence Data , Nucleic Acid Conformation , Phylogeny , RNA, Viral/chemistry , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Viral Vaccines/standardsABSTRACT
The fine immunoreactivity of the rabbit humoral response elicited by four env-recombinant avipoxviruses and their ability to stimulate a memory T-cell response and a protective immunity have been studied. The antibody specificity was compared with the serum neutralizing activity and virus-specific T-cell proliferative response. Resistance to challenge by cell-associated HIV-1 was monitored by PCR. Canarypox (CP) and fowlpox (FP) constructs, containing the complete env gene (IS(+)) from the HIV-1(SF2) strain, induced a higher profile of epitope recognition than their counterparts expressing the env gene deleted of the putative immunosuppressive region (IS(-)). Serum neutralizing activity was in agreement with fusion inhibition and lymphoproliferative response in rabbits immunized with CPIS(+), and only partially with FPIS(+). Rabbits failed to be infected, but anti- p55 gag-specific antibodies could be demonstrated by Western blot. This study confirms the ability of these non-replicative live recombinant viruses to elicit a complete immune response, capable of inhibiting specific HIV-1 functions.
Subject(s)
AIDS Vaccines/immunology , HIV Antibodies/blood , HIV-1/immunology , Vaccines, Synthetic/immunology , AIDS Vaccines/administration & dosage , Animals , Avipoxvirus/genetics , Avipoxvirus/immunology , Cell Line , Epitope Mapping , Fowlpox virus/genetics , Fowlpox virus/immunology , Gene Products, env/genetics , Gene Products, env/immunology , Gene Products, gag/immunology , HIV Infections/immunology , HIV Infections/prevention & control , HIV-1/genetics , HIV-1/physiology , Humans , Immunization , Lymphocyte Activation , Neutralization Tests , Rabbits , Vaccines, Synthetic/administration & dosageABSTRACT
The specific immune mechanisms necessary and/or sufficient to elicit HIV-vaccine protection remain undefined. Utilising the SHIV rhesus macaque model the immunogenicity as well as the efficacy of ten different HIV-1 vaccine candidates was evaluated. Comparison of the immune responses induced, with the ability of the vaccine to protect from SHIV infection provided a means to determine which type of immune responses were necessary for protection. Vaccine candidates included VLPs, DNA, subunit protein with novel adjuvant formulations, ISCOMs and pox-virus vectors. Protection from SHIV infection was achieved in approximately half of the animals which received a primary intravenous cell-free challenge. The presence of CTL in the absence of other effector responses did not correlate with protection from this route and type of challenge. Virus neutralising antibodies (Nab) appeared to be necessary but alone were insufficient for protection. If Ag-specific IFN-gamma and/or IL-4 as well as lymphoproliferative (LP) responses were found with the lack of a detectable IL-2 response, then protection was not observed. Immunity correlated with the magnitude of Nab responses, beta-chemokines and as well as balanced, qualitative T-helper responses.
Subject(s)
AIDS Vaccines/immunology , HIV-1/immunology , Reassortant Viruses/immunology , Simian Acquired Immunodeficiency Syndrome/prevention & control , Simian Immunodeficiency Virus/immunology , Animals , Antibody Formation , Chemokines, CC/immunology , Clinical Trials as Topic , HIV Antibodies/immunology , Humans , Immunity, Cellular , Macaca mulatta , Neutralization Tests , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Helper-Inducer/immunologyABSTRACT
One of the obstacles to AIDS vaccine development is the variability of HIV-1 within individuals and within infected populations, enabling viral escape from highly specific vaccine induced immune responses. An understanding of the different immune mechanisms capable of inhibiting HIV infection may be of benefit in the eventual design of vaccines effective against HIV-1 variants. To study this we first compared the immune responses induced in Rhesus monkeys by using two different immunization strategies based on the same vaccine strain of HIV-1. We then utilized a chimeric simian/HIV that expressed the envelope of a dual tropic HIV-1 escape variant isolated from a later time point from the same patient from which the vaccine strain was isolated. Upon challenge, one vaccine group was completely protected from infection, whereas all of the other vaccinees and controls became infected. Protected macaques developed highest titers of heterologous neutralizing antibodies, and consistently elevated HIV-1-specific T helper responses. Furthermore, only protected animals had markedly increased concentrations of RANTES, macrophage inflammatory proteins 1alpha and 1beta produced by circulating CD8(+) T cells. These results suggest that vaccine strategies that induce multiple effector mechanisms in concert with beta-chemokines may be desired in the generation of protective immune responses by HIV-1 vaccines.
Subject(s)
AIDS Vaccines/administration & dosage , Chemokines, CC/immunology , HIV-1/immunology , Animals , Cytokines/immunology , HIV-1/physiology , Immunity, Cellular , Macaca mulatta , Neutralization Tests , T-Lymphocytes/immunology , T-Lymphocytes/virologyABSTRACT
Four pigtailed macaques were inoculated with an infectious, apathogenic human immunodeficiency virus type 2 (HIV-2) molecular clone (HIV-2KR) and subsequently challenged with a highly pathogenic strain, HIV-2287, together with two naive control animals. After challenge, two animals inoculated with a high dose of the immunizing strain were protected from CD4 decline and immunodeficiency. To examine the role of genetic heterogeneity in protection, fragments of the env gene were amplified from peripheral blood mononuclear cell DNA and plasma RNA of challenged animals by PCR, examined by using a heteroduplex tracking assay (HTA), and sequenced. By HTA, variation was detected principally within the V1 and V2 regions of envelope. Extent of variation in viral DNA clones as assessed by HTA correlated with inoculum size, as did the degree of variation in sequences of clones derived from viral DNA. Conversely, a rapid reduction in the number of plasma viral RNA variants was noted by HTA at 8 weeks postinfection in protected animals; this reduction was not present in naive or unprotected macaques. Sequences derived from plasma viral RNA were found to be more closely related than corresponding viral DNA sequences, and protection correlated with a significant reduction in variation in plasma RNA sequences in animals given the identical inocula of HIV-2287. Nonsynonymous mutations were significantly less prevalent in the protected animals. An additional potential glycosylation site was predicted to be present in the V2 region in all but one clone, and amino acid signatures related to protection were identified in viral DNA and RNA clones within both the V1 and V2 regions. Examination of the role of viral variation in this HIV-2 live-virus vaccine model may provide valuable insights into immunopathogenesis.
Subject(s)
Genetic Variation , HIV-2/genetics , Viral Vaccines/genetics , Amino Acid Sequence , Animals , Base Sequence , CD4 Lymphocyte Count , DNA Primers , DNA, Viral , Genes, env , HIV Infections/immunology , HIV Infections/virology , Lymphocyte Depletion , Macaca nemestrina , Molecular Sequence Data , Phylogeny , RNA, Viral/blood , RNA, Viral/genetics , Sequence Homology, Amino AcidABSTRACT
The dichotomy of type-1 and type-2 T-helper (Th) immune responses is thought to be an obstacle to develop Human immunodeficiency virus-type- (HIV-1) vaccines capable of inducing effective cellular as well as humoral immune responses. Macaca mulatta were immunized using two different HIV-1sf2 envelope vaccine strategies, based on either immune-stimulating complexes (ISCOM) or chimeric Fowlpox (FP) vaccines. One month following the third immunization all animals were heterologously challenged with simian/human immunodeficiency virus (SHIVsf13). Vaccinated monkeys, which were protected had the highest levels of both type-1 and type-2 HIV-1 specific T-helper cell (Th) responses in addition to the highest homologous and heterogenous virus neutralizing antibodies. To determine how long Th responses persisted and if they correlated with protection, animals were rechallenged after waiting for four months without re-boosting. Macaques which maintained the highest gp120-specific type-1 (IFN-gamma) responses were protected, while there was evidence of viral clearance in two others. These findings demonstrate the importance of both or mixed type-1 and type-2 Th responses in HIV-1 vaccine induced immunity while suggesting a possible role of persistent type-1 responses in maintaining protective immunity over time.
Subject(s)
AIDS Vaccines , Gene Products, env/immunology , HIV Antibodies/blood , HIV Envelope Protein gp120/immunology , HIV-1/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Vaccines, Synthetic , Animals , Antibody Formation , Humans , ISCOMs , Immunity, Cellular , Interferon-gamma/biosynthesis , Macaca mulatta , Time FactorsABSTRACT
Synthetic oligonucleotides corresponding to specific V3 loop portions of two HIV-1 isolates, SC and WMJ2, were expressed in the flagella of a Salmonella live-vaccine strain. Expression of the inserted epitopes in flagellin and their exposure at the surface of flagellar filaments were shown by immunoblotting and immunogold labeling with anti-flagellin (Salmonella d) and anti-HIV-1(IIIB) V3 loop peptide sera. Live recombinant Salmonella strains expressing either one of the two V3 loop inserts were administered intraperitoneally to BALB/c mice. All these animals developed antibodies specific for the heterologous glycoprotein 120 (gp120) of HIV-1 MN strain, as detected by enzyme-linked immunosorbent assays (ELISA), two of the sera had neutralizing activity against the heterologous HIV-1 MN strain. Moreover, oral administration of the live Salmonella recombinant strains to mice evoked specific IgA directed against gp120.
Subject(s)
Flagellin/genetics , HIV Antibodies/blood , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/immunology , HIV-1/immunology , Peptide Fragments/genetics , Peptide Fragments/immunology , Salmonella/genetics , Amino Acid Sequence , Animals , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Epitopes/chemistry , Epitopes/genetics , Epitopes/immunology , Flagellin/chemistry , Flagellin/immunology , Gene Expression , HIV Envelope Protein gp120/chemistry , HIV-1/chemistry , Immunization , Mice , Mice, Inbred BALB C , Microscopy, Immunoelectron , Molecular Sequence Data , Peptide Fragments/chemistry , Plasmids , Recombinant Fusion Proteins/immunology , Salmonella/chemistry , Salmonella/immunologyABSTRACT
Accumulating evidence demonstrates that adipose tissue is a major site of tumor necrosis factor-alpha (TNF-alpha) gene expression, which is markedly high in obese animals and may contribute to obesity-linked insulin resistance. We now report that recombinant murine TNF-alpha triggers the apoptotic degeneration of brown adipocytes differentiated in culture. Moreover, noradrenaline, which has been described as having trophic effects on brown fat and accelerating the differentiation of brown adipocytes, is capable of dose-dependently preventing the TNF-alpha-induced apoptosis of brown fat cells. Since obesity is characterized by greatly increased TNF-alpha production and reduced catecholaminergic activity, apoptosis was studied in the brown fat of genetically obese animals. In situ DNA fragmentation analysis revealed a larger number of apoptotic cells in the brown fat of obese (fa/fa) than in that of lean (+/+) Zucker rats. The exposure of obese rats to low temperatures for 7 days, which increases the sympathetic activity of brown adipose tissue, significantly reduces the number of apoptotic brown adipocytes. We hypothesize that TNF-alpha may play a significant role in the control of brown fat homeostasis.
ABSTRACT
Different strategies proposed in the literature to attempt gene therapy of AIDS are based mainly on the intracellular production of RNA and protein therapeutics. This report describes the construction and the anti-human immunodeficiency virus type 1 (HIV-1) activity of a new type of antisense tRNA directed against a nucleotide region in the first coding exon of HIV-1 tat (nucleotides 5924 to 5943; Los Alamos data bank) which is conserved among many HIV-1 clones. The anti-tat antisense sequence was inserted into a tRNA(Pro) backbone by replacement of the anticodon loop, without altering the tRNA canonic tetraloop structure. The antisense tRNA was able to interact effectively with its target in vitro. Jurkat cells that constitutively expressed the anti-tat tRNA following retroviral vector transduction exhibited significant resistance to HIV-1 de novo infection. Resistance seemed to correlate with the level of antisense expression. This is the first time that such a tRNA antisense strategy has been shown to be effective as a genetic treatment of HIV-1 infection in tissue culture. The construct design proposed in this report has some intrinsic advantages: the transcript is driven by a polymerase III promoter, the short length of the RNA minimizes effects of intramolecular base pairing that may impair target recognition, and the antisense RNA has the stability and intracellular fate of a native tRNA molecule.
Subject(s)
Gene Products, tat/genetics , Genetic Therapy , HIV-1/genetics , RNA, Antisense/genetics , RNA, Transfer, Pro/genetics , Base Sequence , Cell Line , Gene Transfer Techniques , Genetic Vectors , HIV Infections/genetics , HIV Infections/therapy , HIV-1/physiology , Humans , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Antisense/chemistry , RNA, Transfer, Pro/chemistry , Retroviridae/genetics , T-Lymphocytes/virology , Virus Replication/genetics , tat Gene Products, Human Immunodeficiency VirusABSTRACT
Recombinant canarypox (CP) and fowlpox (FP) viruses that contained two forms of the HIV-1 (SF2 strain) env gene were engineered and their expression analysed in chick, simian and human cells. These vectors can efficiently replicate in avian but not in mammalian cells, in which infection is abortive. The two forms, consisting of the entire env open reading frame (IS+) or of the same gene lacking the putative immunosuppressive (IS-) region (amino acids 583-599), were individually inserted into the two virus vector backgrounds. In order to avoid premature transcription termination of the foreign gene and to improve protein expression, a mutagenesis was also performed within the T5NT motif without altering the amino acid sequence. By immunoprecipitation analyses, cells infected with CP and FP recombinants expressed HIV-1 env polypeptides of the appropriate molecular weight. We observed that the gp160 precursor was proteolytically cleaved except in MRC-5 cells infected with the IS- recombinants and that these polypeptides were glycosylated. Further analysis of these recombinant viruses by indirect immunofluorescence and syncytia inhibition assays indicated that the gp120 gp41 complex was present on the surface of infected cells, the number of syncytia being significantly lower when cells were infected by the CPIS- or FPIS- recombinants. Moreover, sera of immunized rabbits revealed the presence of specific antibodies in animals inoculated either with CP or with FP recombinants. These new constructs, which are unable to support a productive infection in human cells, might therefore also be a good anti-HIV-1 candidate vaccine in seropositive hosts.
Subject(s)
Avipoxvirus/genetics , Gene Expression Regulation, Viral/genetics , Genes, env/genetics , HIV-1/genetics , Amino Acid Sequence , Animals , Avipoxvirus/immunology , Cell Line , Chick Embryo , Chlorocebus aethiops , Enzyme-Linked Immunosorbent Assay , Fibroblasts/cytology , Fluorescent Antibody Technique , Genetic Vectors , HIV Antibodies/biosynthesis , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp41/genetics , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Open Reading Frames , Peptide Fragments/genetics , Rabbits , Radioimmunoprecipitation Assay , Specific Pathogen-Free Organisms , Transcription, Genetic/genetics , Vero CellsABSTRACT
The canarypox (CP) and fowlpox (FP) viruses, which are unable to replicate productively in non-avian species, have been utilized as live vectors carrying the HIV-1SF2 env gene with the putative immunosuppressive (IS) region complete (CPIS+ and FPIS+) or deleted (CPIS- and FPIS-). To determine if these avipox-env recombinants could be utilized to elicit a specific immune response against HIV-1, six groups of rabbits were immunized with CPIS+, CPIS-, FPIS+, FPIS- constructs or their non-engineered wild-type CPwt or FPwt counterparts. After a primary inoculation and successive boosters, env-specific humoral and cell-mediated immunity were demonstrated by ELISA, immunoblots and lymphoproliferation assays. Antibody titres and neutralization activities were higher in CP- than FP-inoculated rabbits, the CPIS+ always showing a similar immunogenic capacity to CPIS-. Evidence is also presented indicating that rabbit sera possess group-specific antibodies, which were, however, unable to cross-neutralize divergent HIV-1 strains. Although the protective capacity against HIV-1 experimental infection has not yet been determined in these animals, our results suggest that these recombinants might represent promising and safer candidate vaccines against HIV-1.
Subject(s)
Avipoxvirus/genetics , Genes, env/genetics , HIV Antibodies/biosynthesis , HIV-1/genetics , AIDS Vaccines/immunology , Animals , Antibody Specificity , Blotting, Western , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation, Viral/genetics , Genetic Engineering , HIV-1/immunology , Humans , Immune Sera/immunology , Immunity, Cellular , Lymphocyte Activation , Rabbits , T-Lymphocytes/cytology , Time Factors , Vaccination , Vaccines, Synthetic/immunology , Virus Replication/geneticsABSTRACT
We investigated beta-endorphin (BE) content in an HIV-infected cell line and in peripheral blood mononuclear cells (PBM) from HIV-positive subjects. HIV infection increased BE content in HuT78 cell line compared to uninfected cells. Accordingly, BE content was greater in HIV-positive subjects than in healthy controls, both in fresh PBM and in mitogen-stimulated or unstimulated cultured cells. Further, in PHA-stimulated cultures, BE increase was correlated with disease progression. Opioids are known to decrease immune responsiveness in vivo, and it may be that the increased BE concentrations contribute to HIV-associated immune deficiency. In HIV-positive subjects, but not in healthy controls, intracellular BE concentration was positively correlated with PHA-induced PBM proliferation. The latter data suggest an alternative explanation: that the increased BE content represents a paradoxical response of the host in an attempt to balance virus-induced immunodepression. Thus, BE may be important in fine-tuning of the immune response with its up- and downregulation dependent upon differences in immune status.
Subject(s)
HIV Infections/metabolism , HIV Seropositivity/blood , Lymphocytes/metabolism , beta-Endorphin/blood , Adult , Cell Line , Female , HIV Seronegativity/physiology , Humans , Immune Tolerance , Male , Reference Values , Substance Abuse, Intravenous/bloodABSTRACT
Interspecies human x mouse cell hybrids were used to investigate the genetic basis of human permissivity to HTLV-IIIB infection. T cell hybrids between the mouse BW 51.47 T lymphoma line and normal, PHA-IL-2 activated, human peripheral mononuclear cells (PBMCs) were generated. These hybrids preferentially segregated human chromosomes, as assessed by phenotype and karyotype analysis. Viral integration occurred only in those hybrids expressing CD4+ at the cell surface. However, infectious progeny production was demonstrated only in two of the three CD4+ hybrids tested. By segregation analysis, we could correlate the absence of human chromosomes 1, 3, and 9 with the lack of infectious viral progeny.
Subject(s)
HIV Infections/genetics , HIV-1/genetics , Hybrid Cells/microbiology , T-Lymphocytes/microbiology , Animals , Base Sequence , CD4 Antigens/metabolism , Chromosomes, Human , DNA Primers/genetics , DNA, Viral/genetics , Genes, gag , HIV Infections/microbiology , HIV-1/physiology , HIV-1/ultrastructure , Humans , Hybrid Cells/immunology , Hybrid Cells/ultrastructure , Mice , Molecular Sequence Data , T-Lymphocytes/immunology , T-Lymphocytes/ultrastructure , Virus Integration/geneticsABSTRACT
A 10(-3) M methotrexate (MTX)-resistant variant (H2), selected from the murine fibrosarcoma line B77-3T3/AA12, was characterized after 5 (H2 MTXRes I) and 9 (H2 MTXRes II) months of in vitro propagation in the presence of the drug. Southern blot hybridization of wild-type and H2 MTXRes DNAs confirmed amplification of the dhfr gene without apparent rearrangements in its structure. Cytogenetic analysis revealed that double minutes (DMs) predominated in H2 MTXRes I, whereas homogeneously staining regions (HSRs) were the main feature of H2 MTXRes II cells. HSRs, shown to contain dhfr sequences by in situ chromosome hybridization, were localized within two rearranged chromosomes, designated as m1 and m2 because of their derivation from the marker chromosome m of AA12 cells. This chromosome, characterized by two interstitial C bands adjacent to two nonstaining gaps, was no longer observed in H2 MTXRes II cells. A role for nonrandom involvement of chromosome m in the integration of amplified DNA is suggested by the finding of another HSR-chromosome, m3, derived from m, in an independent MTXRes clone (B1). Rearrangement in one of the unstable C-band/gap regions of chromosome m is proposed as the unifying mechanism that may account for the outcome of the three HSR chromosomes observed.
Subject(s)
Chromosome Fragility , Chromosomes/physiology , Gene Amplification , Heterochromatin/physiology , Recombination, Genetic , Tetrahydrofolate Dehydrogenase/genetics , Animals , Blotting, Southern , Chromosome Banding , Chromosome Fragile Sites , Chromosomes/ultrastructure , Drug Resistance , Methotrexate , Mice , Tumor Cells, CulturedABSTRACT
The pattern of response to Epstein-Barr virus (EBV) has been investigated in 17 patients with essential mixed cryoglobulinemia (EMC) and in 17 control subjects. All subjects in both groups had IgG to the viral capsid antigen at comparable titers. In the absence of signs of recent infection, 13 patients had IgM to viral capsid antigen and 5 had also IgA, while all the controls were negative. EBV genome was present in bone marrow lymphocytes obtained from 4 patients with type II EMC, but not in those of one patient with type III disease; the latter patient's lymphocytes also failed to produce detectable levels of rheumatoid factor in culture, while the other four patients' lymphocytes released high amounts in culture supernatants. These data support the evidence of an association between type II EMC and persistent EBV infection.
Subject(s)
Antibodies, Viral/immunology , Cryoglobulinemia/immunology , Herpesviridae Infections/complications , Antigens, Viral/immunology , Capsid/immunology , Cryoglobulinemia/etiology , Cryoglobulinemia/microbiology , DNA, Viral/analysis , Female , Herpesviridae Infections/immunology , Herpesvirus 4, Human/analysis , Herpesvirus 4, Human/immunology , Humans , Male , Middle Aged , Rheumatoid Factor/analysis , Viral Envelope Proteins/immunologyABSTRACT
Retrovirus infectivity is the result of a cooperative interaction of three structural genes, gag, pol, and env. Since the L-cell endogenous retrovirus (LCV) lacks the env gene translation product, our aim was to study the biological and molecular basis of its non-infectiousness. Fusion experiments between LCV and homologous or heterologous cells demonstrated that virus production could be obtained only after LCV artificial penetration in murine cells and that the new progeny was still noninfectious. Northern blot analysis and heteroduplex mapping of the genomic RNA revealed a 0.99 kb deletion including the 3' region of the pol reading frame, the whole xenotropic and part of the ecotropic domain of the env gene. The results suggest that the observed deletion is responsible for the absence of the gp 70 and the gp 15 E molecules in the virion and seems therefore to be the molecular basis for the non-infectiousness of this retrovirus.
Subject(s)
L Cells/microbiology , Retroviridae Proteins/genetics , Retroviridae/genetics , Viral Envelope Proteins/genetics , Blotting, Northern , Chromosome Deletion , Genes, Viral , Membrane Fusion , Nucleic Acid Hybridization , RNA, Viral/genetics , Retroviridae/classification , Retroviridae/growth & development , Sequence Homology, Nucleic Acid , Virus ReplicationABSTRACT
Human choroid (HC) cells transformed by Simian virus 40 (HC/SV40) and some of their soft agar-derived clones were utilized to study the influence of SV40 transformation on the expression of some differentiation parameters. The presence of receptors for DNA and RNA viruses, known to induce cytopathic effects in target cells, always occurred in normal HF and HC/SV40 cells as well as in their derived clones, whereas differences were observed in the expression of influenza A and Sindbis virus receptors. Immunofluorescence assays showed an increase in the expression of class I (HLA-A/B/C) and class II (DR) histocompatibility antigens in hyperdiploid clones compared with both the hypodiploid clones and the normal human cell counterpart. The two surface glycoproteins, fibronectin and laminin, appear only partially correlated with the transformed phenotype of the cells both at optical (immunofluorescence) and supraoptical (immunoelectron microscopy) level. This study confirms the SV40 transformation induces in human choroid cells a modulation of the considered differentiation parameters and that this may be due to a different insertion mode of the SV40 genome in HC cells.
Subject(s)
Amnion/cytology , Cell Transformation, Viral , Histocompatibility Antigens/immunology , Membrane Proteins/metabolism , Receptors, Virus/metabolism , Cell Line , Clone Cells , Disease Susceptibility , Fibroblasts/immunology , Fibronectins/metabolism , Fluorescent Antibody Technique , Humans , Laminin/metabolism , Microscopy, Electron , Simian virus 40/physiology , Skin/cytology , Skin/immunologyABSTRACT
Several clones were isolated from a Simian Virus 40-transformed human choroid cell line (HC/SV40) by the soft agar plating technique. Five of them which showed different morphology, growth capacity and cell density, were plated in monolayer and subjected to ultrastructural, immunological and cytogenetic analyses. The morphological features at both TEM and SEM were distinct for every examined clone but uniform in the cells of the same clone. In particular clone 3 (HC/SV40-C13) showed a greater increase of intracytoplasmic granules, a marker of all cells of choroid origin, while clone 2 (HC/SV40-C12) was totally devoid of them. No virus production was observed at the electron microscope. Immunofluorescence experiments revealed 100% positivity for nuclear T-antigen in all the clones, thus demonstrating the persistence of SV40 genome in these cells. Cytogenetic analysis showed a hyperdiploid number of chromosomes in clones 1 and 3, while clones 2 and 4 were clearly hypodiploid. All clones showed a general tendency to cytogenetic stabilization as compared to the karyotypes found in HC/SV40 parental cell line.